Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism ERK1 inhibitors(Extracellular-signal-regulated kinase1 inhibitors), ERK2 inhibitors(Extracellular-signal-regulated kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 03 Jun 2020 | |
| Colorectal Cancer | IND Application | China | 07 Dec 2019 | |
| Liver Cancer | IND Application | China | 07 Dec 2019 | |
| Lung Cancer | IND Application | China | 07 Dec 2019 | |
| Melanoma | IND Application | China | 07 Dec 2019 | |
| Pancreatic Cancer | IND Application | China | 07 Dec 2019 | |
| Stomach Cancer | IND Application | China | 07 Dec 2019 |





